Sfoglia per Autore
Unfaithful association of FCGR2B genetic polymorphisms with susceptibility to SLE.
2009-01-01 V. Napolioni;A. Barucca;E. Bolli;A. Concetti;F. M. Venanzi
Tumor endothelial marker 8 expression levels in dendritic cell-based cancer vaccines are related to clinical outcome.
2010-01-01 Venanzi FM; Petrini M; Fiammenghi L; Bolli E; Granato AM; Ridolfi L; Gabrielli F; Barucca A; Concetti A; Ridolfi R; Riccobon A.
Oncoantigens for an immune prevention of cancer
2011-01-01 Elisabetta Bolli; Elena Quaglino; Maddalena Arigoni; Pier-Luigi Lollini; Raffaele A. Calogero; Guido Forni; Federica Cavallo
Atorvastatin modulates anti-proliferative and pro-proliferative signals in Her2/neu-positive mammary cancer.
2011-01-01 Riganti C; Pinto H; Bolli E; Belisario DC; Calogero RA; Bosia A; Cavallo F
A study on erm(B)-mediated MLS resistance in Streptococcus pyogenes clinical isolates.
2011-01-01 S. Rombini;D. Petrelli;E. Bolli;C. N. Tran;M. Falconi;M. C. Di;M. Prenna;S. Ripa;L. A. Vitali
Optical imaging detection of microscopic mammary cancer in ErbB-2 transgenic mice through the DA364 probe bindingαvβ3integrins
2013-01-01 Laura Conti;Stefania Lanzardo;Manuela Iezzi;Monica Montone;Elisabetta Bolli;Chiara Brioschi;Alessandro Maiocchi;Guido Forni;Federica Cavallo
Second Ascoli Piceno conference on gene vaccination in cancer (GVC), Ascoli Piceno, Italy, October 9–11, 2013
2014-01-01 Elisabetta Bolli;Laura Conti;Federica Riccardo;Cristina Marchini;Augusto Amici;Federica Cavallo;Elena Quaglino
Antitumor immunization of mothers delays tumor development in cancer-prone offspring
2015-01-01 Barutello, Giuseppina; Curcio, Claudia; Spadaro, Michela; Arigoni, Maddalena; Trovato, Rosalinda; Bolli, Elisabetta; Zheng, Yujuan; Ria, Francesco; Quaglino, Elena; Iezzi, Manuela; Riccardo, Federica; Holmgren, Lars; Forni, Guido; Cavallo, Federica
Immunotargeting of antigen xCT attenuates stem-like cell behavior and metastatic progression in breast cancer
2016-01-01 Lanzardo, Stefania; Conti, Laura; Rooke, Ronald; Ruiu, Roberto; Accart, Nathalie; Bolli, Elisabetta; Arigoni, Maddalena; Macagno, Marco; Barrera, Giuseppina; Pizzimenti, Stefania; Aurisicchio, Luigi; Calogero, Raffaele Adolfo; Cavallo, Federica
Bovine herpesvirus 4-based vector delivering a hybrid rat/human HER-2 oncoantigen efficiently protects mice from autochthonous Her-2+mammary cancer
2016-01-01 Jacca, Sarah; Rolih, Valeria; Quaglino, Elena; Franceschi, Valentina; Tebaldi, Giulia; Bolli, Elisabetta; Rosamilia, Alfonso; Ottonello, Simone; Cavallo, Federica; Donofrio, Gaetano
Chimeric DNA Vaccines: An Effective Way to Overcome Immune Tolerance.
2017-01-01 F. Riccardo;E. Bolli;M. Macagno;M. Arigoni;F. Cavallo;E. Quaglino
A Virus-Like-Particle immunotherapy targeting Epitope-Specific anti-xCT expressed on cancer stem cell inhibits the progression of metastatic cancer in vivo
2018-01-01 Bolli, Elisabetta; O'Rourke, John P.; Conti, Laura; Lanzardo, Stefania*; Rolih, Valeria; Christen, Jayne M.; Barutello, Giuseppina; Forni, Marco; Pericle, Federica; Cavallo, Federica
Bovine herpesvirus 4-based vector delivering the full length xCT DNA efficiently protects mice from mammary cancer metastases by targeting cancer stem cells
2018-01-01 Donofrio, Gaetano; Tebaldi, Giulia; Lanzardo, Stefania; Ruiu, Roberto; Bolli, Elisabetta; Ballatore, Andrea; Rolih, Valeria; Macchi, Francesca; Conti, Laura; Cavallo, Federica*
Fighting breast cancer stem cells through the immune-targeting of the xCT cystine–glutamate antiporter
2019-01-01 Ruiu, Roberto*; Rolih, Valeria; Bolli, Elisabetta; Barutello, Giuseppina; Riccardo, Federica; Quaglino, Elena; Merighi, Irene Fiore; Pericle, Federica; Donofrio, Gaetano; Cavallo, Federica; Conti, Laura
Cancer stem cell immunology and immunotherapy: Harnessing the immune system against cancer's source
2019-01-01 Ruiu R.; Tarone L.; Rolih V.; Barutello G.; Bolli E.; Riccardo F.; Cavallo F.; Conti L.
Targeting neuropilin-1 with nanobodies reduces colorectal carcinoma development
2020-01-01 De Vlaeminck Y.; Bonelli S.; Awad R.M.; Dewilde M.; Rizzolio S.; Lecocq Q.; Bolli E.; Santos A.R.; Laoui D.; Schoonooghe S.; Tamagnone L.; Goyvaerts C.; Mazzone M.; Breckpot K.; Van Ginderachter J.A.
Immunotargeting of the xCT Cystine/Glutamate Antiporter Potentiates the Efficacy of HER2-Targeted Immunotherapies in Breast Cancer
2020-01-01 Conti L.; Bolli E.; Di Lorenzo A.; Franceschi V.; Macchi F.; Riccardo F.; Ruiu R.; Russo L.; Quaglino E.; Donofrio G.; Cavallo F.
Toll-like receptor 2 at the crossroad between cancer cells, the immune system, and the microbiota
2020-01-01 Di Lorenzo A.; Bolli E.; Tarone L.; Cavallo F.; Conti L.
Development of a vlp-based vaccine displaying an XCT extracellular domain for the treatment of metastatic breast cancer
2020-01-01 Rolih V.; Caldeira J.; Bolli E.; Salameh A.; Conti L.; Barutello G.; Riccardo F.; Magri J.; Lamolinara A.; Parra K.; Valenzuela P.; Francia G.; Iezzi M.; Pericle F.; Cavallo F.
IL1b promotes immune suppression in the tumor microenvironment independent of the inflammasome and gasdermin D
2021-01-01 Kiss M.; Walle L.V.; Saavedra P.H.V.; Lebegge E.; van Damme H.; Murgaski A.; Qian J.; Ehling M.; Pretto S.; Bolli E.; Keirsse J.; Bardet P.M.R.; Arnouk S.M.; Elkrim Y.; Schmoetten M.; Brughmans J.; Debraekeleer A.; Fossoul A.; Boon L.; Raes G.; van Loo G.; Lambrechts D.; Mazzone M.; Beschin A.; Wullaert A.; Lamkanfi M.; van Ginderachter J.A.; Laoui D.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Unfaithful association of FCGR2B genetic polymorphisms with susceptibility to SLE. | 2009 | V. Napolioni;A. Barucca;E. Bolli;A. Concetti;F. M. Venanzi | |
Tumor endothelial marker 8 expression levels in dendritic cell-based cancer vaccines are related to clinical outcome. | 2010 | Venanzi FM; Petrini M; Fiammenghi L; Bolli E; Granato AM; Ridolfi L; Gabrielli F; Barucca A; Concetti A; Ridolfi R; Riccobon A. | |
Oncoantigens for an immune prevention of cancer | 2011 | Elisabetta Bolli; Elena Quaglino; Maddalena Arigoni; Pier-Luigi Lollini; Raffaele A. Calogero; Guido Forni; Federica Cavallo | |
Atorvastatin modulates anti-proliferative and pro-proliferative signals in Her2/neu-positive mammary cancer. | 2011 | Riganti C; Pinto H; Bolli E; Belisario DC; Calogero RA; Bosia A; Cavallo F | |
A study on erm(B)-mediated MLS resistance in Streptococcus pyogenes clinical isolates. | 2011 | S. Rombini;D. Petrelli;E. Bolli;C. N. Tran;M. Falconi;M. C. Di;M. Prenna;S. Ripa;L. A. Vitali | |
Optical imaging detection of microscopic mammary cancer in ErbB-2 transgenic mice through the DA364 probe bindingαvβ3integrins | 2013 | Laura Conti;Stefania Lanzardo;Manuela Iezzi;Monica Montone;Elisabetta Bolli;Chiara Brioschi;Alessandro Maiocchi;Guido Forni;Federica Cavallo | |
Second Ascoli Piceno conference on gene vaccination in cancer (GVC), Ascoli Piceno, Italy, October 9–11, 2013 | 2014 | Elisabetta Bolli;Laura Conti;Federica Riccardo;Cristina Marchini;Augusto Amici;Federica Cavallo;Elena Quaglino | |
Antitumor immunization of mothers delays tumor development in cancer-prone offspring | 2015 | Barutello, Giuseppina; Curcio, Claudia; Spadaro, Michela; Arigoni, Maddalena; Trovato, Rosalinda; Bolli, Elisabetta; Zheng, Yujuan; Ria, Francesco; Quaglino, Elena; Iezzi, Manuela; Riccardo, Federica; Holmgren, Lars; Forni, Guido; Cavallo, Federica | |
Immunotargeting of antigen xCT attenuates stem-like cell behavior and metastatic progression in breast cancer | 2016 | Lanzardo, Stefania; Conti, Laura; Rooke, Ronald; Ruiu, Roberto; Accart, Nathalie; Bolli, Elisabetta; Arigoni, Maddalena; Macagno, Marco; Barrera, Giuseppina; Pizzimenti, Stefania; Aurisicchio, Luigi; Calogero, Raffaele Adolfo; Cavallo, Federica | |
Bovine herpesvirus 4-based vector delivering a hybrid rat/human HER-2 oncoantigen efficiently protects mice from autochthonous Her-2+mammary cancer | 2016 | Jacca, Sarah; Rolih, Valeria; Quaglino, Elena; Franceschi, Valentina; Tebaldi, Giulia; Bolli, Elisabetta; Rosamilia, Alfonso; Ottonello, Simone; Cavallo, Federica; Donofrio, Gaetano | |
Chimeric DNA Vaccines: An Effective Way to Overcome Immune Tolerance. | 2017 | F. Riccardo;E. Bolli;M. Macagno;M. Arigoni;F. Cavallo;E. Quaglino | |
A Virus-Like-Particle immunotherapy targeting Epitope-Specific anti-xCT expressed on cancer stem cell inhibits the progression of metastatic cancer in vivo | 2018 | Bolli, Elisabetta; O'Rourke, John P.; Conti, Laura; Lanzardo, Stefania*; Rolih, Valeria; Christen, Jayne M.; Barutello, Giuseppina; Forni, Marco; Pericle, Federica; Cavallo, Federica | |
Bovine herpesvirus 4-based vector delivering the full length xCT DNA efficiently protects mice from mammary cancer metastases by targeting cancer stem cells | 2018 | Donofrio, Gaetano; Tebaldi, Giulia; Lanzardo, Stefania; Ruiu, Roberto; Bolli, Elisabetta; Ballatore, Andrea; Rolih, Valeria; Macchi, Francesca; Conti, Laura; Cavallo, Federica* | |
Fighting breast cancer stem cells through the immune-targeting of the xCT cystine–glutamate antiporter | 2019 | Ruiu, Roberto*; Rolih, Valeria; Bolli, Elisabetta; Barutello, Giuseppina; Riccardo, Federica; Quaglino, Elena; Merighi, Irene Fiore; Pericle, Federica; Donofrio, Gaetano; Cavallo, Federica; Conti, Laura | |
Cancer stem cell immunology and immunotherapy: Harnessing the immune system against cancer's source | 2019 | Ruiu R.; Tarone L.; Rolih V.; Barutello G.; Bolli E.; Riccardo F.; Cavallo F.; Conti L. | |
Targeting neuropilin-1 with nanobodies reduces colorectal carcinoma development | 2020 | De Vlaeminck Y.; Bonelli S.; Awad R.M.; Dewilde M.; Rizzolio S.; Lecocq Q.; Bolli E.; Santos A.R.; Laoui D.; Schoonooghe S.; Tamagnone L.; Goyvaerts C.; Mazzone M.; Breckpot K.; Van Ginderachter J.A. | |
Immunotargeting of the xCT Cystine/Glutamate Antiporter Potentiates the Efficacy of HER2-Targeted Immunotherapies in Breast Cancer | 2020 | Conti L.; Bolli E.; Di Lorenzo A.; Franceschi V.; Macchi F.; Riccardo F.; Ruiu R.; Russo L.; Quaglino E.; Donofrio G.; Cavallo F. | |
Toll-like receptor 2 at the crossroad between cancer cells, the immune system, and the microbiota | 2020 | Di Lorenzo A.; Bolli E.; Tarone L.; Cavallo F.; Conti L. | |
Development of a vlp-based vaccine displaying an XCT extracellular domain for the treatment of metastatic breast cancer | 2020 | Rolih V.; Caldeira J.; Bolli E.; Salameh A.; Conti L.; Barutello G.; Riccardo F.; Magri J.; Lamolinara A.; Parra K.; Valenzuela P.; Francia G.; Iezzi M.; Pericle F.; Cavallo F. | |
IL1b promotes immune suppression in the tumor microenvironment independent of the inflammasome and gasdermin D | 2021 | Kiss M.; Walle L.V.; Saavedra P.H.V.; Lebegge E.; van Damme H.; Murgaski A.; Qian J.; Ehling M.; Pretto S.; Bolli E.; Keirsse J.; Bardet P.M.R.; Arnouk S.M.; Elkrim Y.; Schmoetten M.; Brughmans J.; Debraekeleer A.; Fossoul A.; Boon L.; Raes G.; van Loo G.; Lambrechts D.; Mazzone M.; Beschin A.; Wullaert A.; Lamkanfi M.; van Ginderachter J.A.; Laoui D. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile